A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Apalutamide is under clinical development by Johnson & Johnson and currently in Phase II for Prostate Cancer. According to GlobalData, Phase II drugs for Prostate Cancer have a 23% phase transition ...

For the men who have beat prostate cancer once, 20 to 30 percent will show signs of recurrence after the five-year mark following their initial treatment. Another round of therapies can be complicated ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

The findings show that more extensive research on how pesticides impact the development and severity of various cancers is ...

Discovery May Open New Way to Attack Prostate Cancer Dec. 3, 2024 — A special protein can play a key role in the fight against certain types of prostate cancer. Until now, treatments have ...

The AP reported that Netanyahu is expected to remain in the hospital for several days. According to Johns Hopkins Medicine, it is recommended not to perform strenuous activity or heavy lifting for at ...

King Charles III was diagnosed with cancer earlier this year after a hospital visit for an enlarged prostate. This is how treatment is going.